Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas
A Bucko, Michael Jarratt, Dowling B. Stough, et al.
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 1, pp. 74-79
Closed Access | Times Cited: 10

Showing 10 citing articles:

Safety of topical interventions for the treatment of actinic keratosis
Elias A. T. Koch, Anja Wessely, Theresa Steeb, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 801-814
Closed Access | Times Cited: 11
Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm2 on the chest: A phase 3 randomized controlled trial
C. William Hanke, Lorne Albrecht, Torsten Skov, et al.
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 3, pp. 642-650
Closed Access | Times Cited: 11
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis
Eggert Stockfleth, Mike Bastian
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 14, Iss. 9, pp. 911-918
Closed Access | Times Cited: 11
Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP
Uly Sumarni, Ulrich Reidel, Jürgen Eberle
Cells (2021) Vol. 10, Iss. 5, pp. 987-987
Open Access | Times Cited: 8
Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
Aleksandra Lesiak, Anna Maćkowska, Igor Bednarski, et al.
Advances in Dermatology and Allergology (2019) Vol. 36, Iss. 4, pp. 468-471
Open Access | Times Cited: 2
Ingenol mebutate 0·015% gel is safe for short‐term treatment of actinic keratoses on the face in solid organ transplant recipients
Lauren Crow, Joyce T. Yuan, Christine Aroyan, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 3, pp. 575-577
Closed Access | Times Cited: 2
Full face ingenol mebutate for actinic keratosis: patient perspective
Eleni Anthony, Karyn Lun, Saxon D. Smith
International Journal of Dermatology (2018) Vol. 58, Iss. 1
Open Access | Times Cited: 1
Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis
Edward Lain, Torsten Skov, Anders Hall
Clinical Drug Investigation (2017) Vol. 38, Iss. 3, pp. 249-257
Closed Access
Topical Therapy for the Treatment of Basal Cell Carcinoma
Natalie Kash, Sirunya Silapunt
Springer eBooks (2019), pp. 49-81
Closed Access
Ingenol Mebutate Induced Severe, Febrile Pustular Eruption of the Face.
Εfstathios Rallis, Angeliki Liakopoulou
PubMed (2019) Vol. 12, Iss. 12, pp. 12-12
Closed Access
Page 1

Scroll to top